Click for best price
Ocular Drug Delivery Market Size, Share 2022
Market Analysis and Insights: Global Ocular Drug Delivery Market
The global Ocular Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ocular Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ocular Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ocular Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ocular Drug Delivery market.
Global Ocular Drug Delivery Scope and Market Size
Ocular Drug Delivery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Ocular Drug Delivery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Ocular Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Ocular Drug Delivery, with price, sales, revenue, and global market share of Ocular Drug Delivery from 2019 to 2022.
Chapter 3, the Ocular Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ocular Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Ocular Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ocular Drug Delivery.
Chapter 13, 14, and 15, to describe Ocular Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Ocular Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Ocular Drug Delivery Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Global Ocular Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Ocular Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Ocular Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Ocular Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Ocular Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Ocular Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Ocular Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Ocular Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Ocular Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Ocular Drug Delivery Market Dynamics
1.5.1 Ocular Drug Delivery Industry Trends
1.5.2 Ocular Drug Delivery Market Drivers
1.5.3 Ocular Drug Delivery Market Challenges
1.5.4 Ocular Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Ocular Drug Delivery Market Segment by Type
2.1.1 Ocular Insert
2.1.2 Iontophoresis
2.1.3 Intraocular Implants
2.1.4 In Situ Gel & Punctal Plugs
2.1.5 Others
2.2 Global Ocular Drug Delivery Market Size by Type
2.2.1 Global Ocular Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Ocular Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Ocular Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Ocular Drug Delivery Market Size by Type
2.3.1 United States Ocular Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Ocular Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Ocular Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Ocular Drug Delivery Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Ophthalmic Clinics
3.1.4 Homecare Settings
3.2 Global Ocular Drug Delivery Market Size by Application
3.2.1 Global Ocular Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Ocular Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Ocular Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Ocular Drug Delivery Market Size by Application
3.3.1 United States Ocular Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Ocular Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Ocular Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ocular Drug Delivery Competitor Landscape by Company
4.1 Global Ocular Drug Delivery Market Size by Company
4.1.1 Top Global Ocular Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Ocular Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Ocular Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Ocular Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Ocular Drug Delivery Concentration Ratio (CR)
4.2.1 Ocular Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ocular Drug Delivery in 2021
4.2.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Ocular Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Ocular Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Ocular Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Ocular Drug Delivery Market Size by Company
4.5.1 Top Ocular Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Ocular Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Ocular Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Ocular Drug Delivery Market Size by Region
5.1 Global Ocular Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Ocular Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Ocular Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Ocular Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Ocular Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Ocular Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Ocular Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Ocular Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 OCULAR THERAPEUTIX, INC
7.1.1 OCULAR THERAPEUTIX, INC Corporation Information
7.1.2 OCULAR THERAPEUTIX, INC Description and Business Overview
7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
7.1.5 OCULAR THERAPEUTIX, INC Recent Development
7.2 Alimera Sciences
7.2.1 Alimera Sciences Corporation Information
7.2.2 Alimera Sciences Description and Business Overview
7.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
7.2.5 Alimera Sciences Recent Development
7.3 Allergan, Plc
7.3.1 Allergan, Plc Corporation Information
7.3.2 Allergan, Plc Description and Business Overview
7.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
7.3.5 Allergan, Plc Recent Development
7.4 EyeGate Pharma
7.4.1 EyeGate Pharma Corporation Information
7.4.2 EyeGate Pharma Description and Business Overview
7.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
7.4.5 EyeGate Pharma Recent Development
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
7.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
7.5.5 Valeant Pharmaceuticals International, Inc Recent Development
7.6 Envisia Therapeutics
7.6.1 Envisia Therapeutics Corporation Information
7.6.2 Envisia Therapeutics Description and Business Overview
7.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
7.6.5 Envisia Therapeutics Recent Development
7.7 Clearside Biomedical
7.7.1 Clearside Biomedical Corporation Information
7.7.2 Clearside Biomedical Description and Business Overview
7.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
7.7.5 Clearside Biomedical Recent Development
7.8 Graybug Vision Inc
7.8.1 Graybug Vision Inc Corporation Information
7.8.2 Graybug Vision Inc Description and Business Overview
7.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
7.8.5 Graybug Vision Inc Recent Development
7.9 Taiwan Liposome Company
7.9.1 Taiwan Liposome Company Corporation Information
7.9.2 Taiwan Liposome Company Description and Business Overview
7.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
7.9.5 Taiwan Liposome Company Recent Development
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Corporation Information
7.10.2 Santen Pharmaceutical Description and Business Overview
7.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
7.10.5 Santen Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Ocular Drug Delivery Industry Chain Analysis
8.2 Ocular Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Ocular Drug Delivery Distributors
8.3 Ocular Drug Delivery Production Mode & Process
8.4 Ocular Drug Delivery Sales and Marketing
8.4.1 Ocular Drug Delivery Sales Channels
8.4.2 Ocular Drug Delivery Distributors
8.5 Ocular Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ocular Drug Delivery CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Ocular Drug Delivery Market Trends
Table 3. Ocular Drug Delivery Market Drivers
Table 4. Ocular Drug Delivery Market Challenges
Table 5. Ocular Drug Delivery Market Restraints
Table 6. Global Ocular Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Ocular Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Ocular Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Ocular Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Ocular Drug Delivery Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Ocular Drug Delivery Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Ocular Drug Delivery Revenue Share by Manufacturer, 2017-2022
Table 13. Global Ocular Drug Delivery Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Ocular Drug Delivery Sales Share by Manufacturer, 2017-2022
Table 15. Global Ocular Drug Delivery Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2021)
Table 18. Top Players of Ocular Drug Delivery in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Ocular Drug Delivery Product Type
Table 20. Date of International Manufacturers Enter into Ocular Drug Delivery Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Ocular Drug Delivery Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Ocular Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Ocular Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Ocular Drug Delivery Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Ocular Drug Delivery Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Ocular Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Ocular Drug Delivery Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Ocular Drug Delivery Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Ocular Drug Delivery Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Ocular Drug Delivery Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Ocular Drug Delivery Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Ocular Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. OCULAR THERAPEUTIX, INC Corporation Information
Table 43. OCULAR THERAPEUTIX, INC Description and Business Overview
Table 44. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product
Table 46. OCULAR THERAPEUTIX, INC Recent Development
Table 47. Alimera Sciences Corporation Information
Table 48. Alimera Sciences Description and Business Overview
Table 49. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Alimera Sciences Product
Table 51. Alimera Sciences Recent Development
Table 52. Allergan, Plc Corporation Information
Table 53. Allergan, Plc Description and Business Overview
Table 54. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Allergan, Plc Product
Table 56. Allergan, Plc Recent Development
Table 57. EyeGate Pharma Corporation Information
Table 58. EyeGate Pharma Description and Business Overview
Table 59. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. EyeGate Pharma Product
Table 61. EyeGate Pharma Recent Development
Table 62. Valeant Pharmaceuticals International, Inc Corporation Information
Table 63. Valeant Pharmaceuticals International, Inc Description and Business Overview
Table 64. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Valeant Pharmaceuticals International, Inc Product
Table 66. Valeant Pharmaceuticals International, Inc Recent Development
Table 67. Envisia Therapeutics Corporation Information
Table 68. Envisia Therapeutics Description and Business Overview
Table 69. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Envisia Therapeutics Product
Table 71. Envisia Therapeutics Recent Development
Table 72. Clearside Biomedical Corporation Information
Table 73. Clearside Biomedical Description and Business Overview
Table 74. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Clearside Biomedical Product
Table 76. Clearside Biomedical Recent Development
Table 77. Graybug Vision Inc Corporation Information
Table 78. Graybug Vision Inc Description and Business Overview
Table 79. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Graybug Vision Inc Product
Table 81. Graybug Vision Inc Recent Development
Table 82. Taiwan Liposome Company Corporation Information
Table 83. Taiwan Liposome Company Description and Business Overview
Table 84. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 85. Taiwan Liposome Company Product
Table 86. Taiwan Liposome Company Recent Development
Table 87. Santen Pharmaceutical Corporation Information
Table 88. Santen Pharmaceutical Description and Business Overview
Table 89. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 90. Santen Pharmaceutical Product
Table 91. Santen Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Ocular Drug Delivery Customers List
Table 95. Ocular Drug Delivery Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Ocular Drug Delivery Product Picture
Figure 2. Global Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Ocular Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 4. Global Ocular Drug Delivery Sales 2017-2028 (K Doses)
Figure 5. United States Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Ocular Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 7. United States Ocular Drug Delivery Sales 2017-2028 (K Doses)
Figure 8. United States Ocular Drug Delivery Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Ocular Drug Delivery Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Ocular Drug Delivery Report Years Considered
Figure 11. Product Picture of Ocular Insert
Figure 12. Product Picture of Iontophoresis
Figure 13. Product Picture of Intraocular Implants
Figure 14. Product Picture of In Situ Gel & Punctal Plugs
Figure 15. Product Picture of Others
Figure 16. Global Ocular Drug Delivery Market Share by Type in 2022 & 2028
Figure 17. Global Ocular Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Ocular Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Ocular Drug Delivery Sales by Type (2017-2028) & (K Doses)
Figure 20. Global Ocular Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Ocular Drug Delivery Price by Type (2017-2028) & (USD/Dose)
Figure 22. United States Ocular Drug Delivery Market Share by Type in 2022 & 2028
Figure 23. United States Ocular Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Ocular Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Ocular Drug Delivery Sales by Type (2017-2028) & (K Doses)
Figure 26. United States Ocular Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Ocular Drug Delivery Price by Type (2017-2028) & (USD/Dose)
Figure 28. Product Picture of Hospitals
Figure 29. Product Picture of Ambulatory Surgical Centers
Figure 30. Product Picture of Ophthalmic Clinics
Figure 31. Product Picture of Homecare Settings
Figure 32. Global Ocular Drug Delivery Market Share by Application in 2022 & 2028
Figure 33. Global Ocular Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Ocular Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Ocular Drug Delivery Sales by Application (2017-2028) & (K Doses)
Figure 36. Global Ocular Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Ocular Drug Delivery Price by Application (2017-2028) & (USD/Dose)
Figure 38. United States Ocular Drug Delivery Market Share by Application in 2022 & 2028
Figure 39. United States Ocular Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Ocular Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Ocular Drug Delivery Sales by Application (2017-2028) & (K Doses)
Figure 42. United States Ocular Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Ocular Drug Delivery Price by Application (2017-2028) & (USD/Dose)
Figure 44. North America Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 45. North America Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 49. Europe Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 56. Asia-Pacific Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 68. Latin America Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 73. Middle East & Africa Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. U.A.E Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Ocular Drug Delivery Value Chain
Figure 78. Ocular Drug Delivery Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
